hotspot -WSS

hotspot

author：leisure time 2025-09-03 11:50:33 - browse：72

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Illumina slashes 2023 revenue projections yet again

WSS

NIH launches clinical trials and new research office for long Covid

Illumina slashes 2023 revenue projections yet again

Maui wildfire now ranks as the fifth

Senators push IRS to launch nonprofit hospital probe

Novo Nordisk touts Wegovy study, but still struggling with supply

Idaho college killings prosecutors challenge defense's grand jury claims

hotspot

hotspot

hotspot

Affirmative action in medical school literally saved lives

NIH launches clinical trials and new research office for long Covid

Anesthesiologist group: stop taking Ozempic before surgery

Maui wildfire now ranks as the fifth

At least 13 dead in Texas as scorching temps continue

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Continuity nursing helped my family in our darkest PICU moments

Trump indictment: Who are the 'co

Medical records are filled with copy

After Optum profits sink, UnitedHealth makes changes

explore

Treatments for cramps don't cut it. Why aren't there better options?

EQRx, failed developer of low

Breakthrough Alzheimer’s drugs are inaccessible in rural states

NIH launches clinical trials and new research office for long Covid

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Physician groups backed by private equity giant lobby on mergers

Wikipedia

focus

focus

focus